VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1725591
Sex: F
Age:
State: NY

Vax Date: 09/17/2021
Onset Date: 09/19/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Left arm bicep swollen; Left armpit swollen; Painful to light touch down to breast; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an unspecified route of administration in the left arm on 17Sep2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamin b complex (MANUFACTURER UNKNOWN) as over the counter (OTC) from an unknown date for unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0185) via an unspecified route of administration in the right arm on 25Aug2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. On 19Sep2021, the patient experienced left arm bicep swollen, left armpit swollen and painful to light touch down to breast. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events left arm bicep swollen, left armpit swollen and painful to light touch down to breast were not resolved at the time of this report.

Other Meds: VITAMIN B COMPLEX

Current Illness:

ID: 1725592
Sex: F
Age:
State: IL

Vax Date: 07/16/2021
Onset Date: 08/15/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210104; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Menstrual Cycle - have been having a period for over a month now; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 16Jul2021(at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 04Jan2021, the patient underwent nasal swab test and the result was unknown. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on an unknown date, as a single dose for COVID-19 immunisation. On 15Aug2021, the patient was having a period for over a month. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19 (also reported as yes). The clinical outcome of the event having a period for over a month was not resolved at the time of this report.

Other Meds:

Current Illness:

ID: 1725593
Sex: M
Age:
State: CA

Vax Date: 08/25/2021
Onset Date: 08/28/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210915; Test Name: Saliva; Test Result: Negative

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Dizziness; Headache; This is a spontaneous report from a non-contactable nurse, the patient. A 39-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration in the right arm on 25Aug2021 at 13:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included sciatica and environmental sleep disorder. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received sulfamethoxazole; trimethoprim (SEPTRA) and experienced drug allergy. On 28Aug2021, the patient experienced dizziness and headache. The patient was still experiencing after 21 days. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had been tested for COVID-19. On 15Sep2021, the patient underwent COVID-19 via saliva test and the result found to be negative. The clinical outcome of the events dizziness and headache was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1725594
Sex: F
Age:
State:

Vax Date: 02/19/2021
Onset Date: 03/01/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data: Test Date: 202108; Test Name: Pulse; Result Unstructured Data: Test Result:89; Comments: Pulse checked it was 112. After a few minutes it went down to 89; Test Date: 202108; Test Name: Pulse; Result Unstructured Data: Test Result:112; Comments: Pulse checked it was 112

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Heart felt like it was going to burst out of the chest when pulse checked it was 112 and after a few minutes it went down to 89; Sharp onset of Migraines; Intense heart beating when sitting; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 35-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3249) via intramuscular route of administration in the left arm on 19Feb2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021, the patient experienced sharp onset of migraines and intense heart beating when sitting. On an unknown date in Aug2021 (also reported as the most recent was last month), the patient experienced that his heart felt like it was going to burst out of her chest and when the patient checked the pulse it was 112 and after a few minutes it went down to 89. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sharp onset of migraines and intense heart beating when sitting was unknown while that of the event heart felt like it was going to burst out of the chest when pulse checked it was 112 and after a few minutes it went down to 89 was resolved on an unknown date in Aug2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

Date Died: 07/04/2021

ID: 1725595
Sex: M
Age:
State:

Vax Date: 03/01/2021
Onset Date:
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Major heart attack; He kept getting sick back to back; This is a spontaneous report from a non-contactable consumer. This consumer reported for a male patient (reporter's father) that a male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on Mar2021 (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient suffered a major heart attack and passed was on 04Jul2021. Ever since the vaccine was given to him, he kept getting sick back to back in 2021. He was never diagnosed with anything before the shot. The outcome of event getting sick back to back was unknown. The outcome of event major heart attack was fatal. The patient died on 04Jul2021. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: major heart attack

Other Meds:

Current Illness:

ID: 1725597
Sex: F
Age:
State:

Vax Date: 07/10/2021
Onset Date: 07/21/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Pain from left knee replacement; Pain from left knee replacement; This is a solicited report received from marketing program 'Facilitated Collect' based on the information received by Pfizer (MFR Control No. # 21K-163- 4026604-00) from a consumer (patient). The consumer reported two reports for same patient and different doses, this is the second of two reports for second dose. A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 intramuscular on 10Jul2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for Covid-19 vaccination; upadacitinib (RINVOQ), oral from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at unspecified dose for moderate to severe rheumatoid arthritis. The patient medical history and concomitant medications were not reported. It was unknown if patient was enrolled in a covid-19 vaccine trial. In 2021, patient received 1st dose covid-19 vaccine manufactured by Pfizer BioNTech. She had covid a couple of weeks after the first vaccine for covid. On 10Jul2021, patient received 2nd dose covid-19 vaccine manufactured by Pfizer BioNTech. On 21Jul2021, the patient had knee replacement and experienced pain from left knee replacement. Pfizer biontech covid-19 vaccine (Tozinameran) was also considered suspect. The patient was still having pain from left knee replacement done on 21Jul2021. In 2021, the patient experienced pain from left knee replacement. The action taken in response to upadacitinib for events was unknown. The patient outcome was not recovered from the pain, of other events was unknown. Causality for RINVOQ(UPADACITINIB): The reporter's causality for the events of pain from left knee replacement onset 21Jul2021, pain from left knee replacement onset in 2021 and covid was not provided. AbbVies opinion is that there is no reasonable possibility that the events of pain from left knee replacement onset 21Jul2021, pain from left knee replacement onset in 2021 and COVID are related to RINVOQ (UPADACITINIB). Causality for vaccine: The reporter's causality for COVID-19 was possible, for other events was not reported. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on available information, the events of Joint injury and Procedural pain are assessed as not related to BNT162B2, and more likely due to underlying medical condition of Rheumatoid arthritis for which patient underwent Knee replacement.,Linked Report(s) : US-PFIZER INC-202101170219 same reporter/ patient, different dose/AE

Other Meds: RINVOQ

Current Illness:

ID: 1725598
Sex: F
Age:
State:

Vax Date: 09/01/2021
Onset Date: 09/01/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Gave her the full vial undiluted with the five to six doses in it; she had that large amount; Gave her the full vial undiluted with the five to six doses in it; she had that large amount; Arm soreness; She on the second day did not feel so well; This is a spontaneous report from a contactable consumer (parent). A 16-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, batch/lot number was not reported), dose 2 via an unspecified route of administration on Sep2021 as dose 2, single for covid-19 immunization. The patient previously received BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, batch/lot number was not reported) as dose 1, single for covid-19 immunization. The patient concomitant medications was not reported. As it was reported on Sep2021 daughter received the full vial undiluted with the five to six doses in it; she had that large amount and also patient experienced arm soreness and patient on the second day did not feel so well. For the events arm soreness and on the second day did not feel so well was recovering. Outcome of the event gave her the full vial undiluted with the five to six doses in it; she had that large amount was unknown. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1725599
Sex: F
Age:
State: NC

Vax Date: 02/24/2021
Onset Date: 03/01/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Shingles/nasty shingles infection; Blisters on the side of her trunk and the right side of her back; Awful pain under the right rib cage; Discomfort; Nerve pain; This is a spontaneous report from a Pfizer sponsored program support. A contactable 68-year-old female consumer (patient) reported for herself who received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number: EN6203 and expiry date was not reported), via an unspecified route of administration, administered in right arm on 24Feb2021 after 16:00 (at the age of 68-year-old) as single dose for covid-19 immunization. Historical vaccine included received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number: EN9581 and expiry date was not reported), via an unspecified route of administration, administered in right arm on 05Feb2021 16:15 (at the age of 68-year-old) as single dose for covid-19 immunization and experienced taste the vaccine immediately and she had polio vaccine when she was 6-years-old and had fever and was sick. Medical history included obese with start and stop date as unspecified, and she had flu maybe 5 years ago from being in an elevator with little kids on vacation. Family medical history relevant to event shingles was no. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included Xarelto (rivaroxaban) 10 mg, low dose, with unspecified start date (she had been using it maybe 2 years), still ongoing for blood thinner. On the end of Mar2021, patient had awful pain under the right rib cage and discomfort. The pain preceded the actual shingles, and it was in her right side, under her rib cage. It was really uncomfortable, and it was awful pain. It persisted long enough until she finally called and made a doctor's appointment. They did not know what it was, at first. It was not until the shingles presented themselves that Thursday, 02Apr2021. She went in by 5Apr2021 or 6Apr2021 and they presented themselves. That was when the medicine was prescribed, and she started taking the medication after that. On beginning of Apr2021, patient developed shingles, nasty shingles infection after getting both doses. It lasted a lot longer than normal shingles. It was there entire month of Apr2021, and she did not get over it until sometime in May2021. She had the blisters, on the right side of her trunk and the right side of her back. That spread and were concentrated on the right side. On an unspecified date in 2021, patient had nerve pain and after a week, she was prescribed some kind of medication that dealt with nerve ending pain. She may have taken that one time. She does not remember the name but, the doctor would probably remember the name. There was another pain medication, not the nerve ending pain medication, she was prescribed a couple of different things. She was scheduled to take an ultrasound of her stomach, because her doctor was trying to see what was going on in that area. She was scheduled to take that this past Saturday but, they could not. They had some difficulty, and it was with an intravenous injection with contrast. They could not try the intravenous because they could not find the vein. She never had that problem before, and she decided not to let her do it anymore. She was scheduled not too long from now to go. Hopefully, somebody else does it and not that other person. She has never been a hard stick and she does not know what the challenge was. Patient took Valtrex for shingles to push out, so her body could cycle. She was prescribed pain medication as well. Ultimately, she got some Oxycodone, she thinks, that worked. The other medication that was prescribed was too strong and she could not take that. Then, she got some variation of Oxycodone or something that helped. She could take the medication as needed. She has a high tolerance for pain and doesn't particularly care for taking pain medication but, she has to sometimes. She also took intermittently, Tylenol with Codeine, they might have prescribed. She could take Tylenol extra strength as well. It was Sep2021, she does not have any effects. Present, there was some transition and lasting issues for a long time. She thought she was never going to get over it. She has no effects at the moment that she was aware of. The pain has stopped for the most part. There was still discomfort in that spot every now and then. The outcome of the events shingles, nasty shingles infection and blisters on the side of her trunk and the right side of her back were recovered on May2021, event discomfort was not recovered and remaining all events outcome was reported as recovered in 2021.

Other Meds: XARELTO

Current Illness:

ID: 1725600
Sex: F
Age:
State: VA

Vax Date: 09/08/2021
Onset Date: 09/09/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Swollen left sided supraclavicular lymph node, now almost two weeks out still swollen; This is a spontaneous report from a contactable nurse, the patient. A 29-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 301308A) via an unspecified route of administration in the left arm on 08Sep2021 at 15:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included supraventricular tachycardia (SVT), rheumatoid arthritis, postural orthostatic tachycardia syndrome (POTS), fatty liver, eosinophilic esophagitis, asthma, COVID-19 and allergy to contrast iodine. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Aug2021 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient previously took clarithromycin (MANUFACTURER UNKNOWN) and ketorolac tromethamine (TORADOL) both for an unknown indication from unknown date and experienced drug allergy. On 09Sep2021, the patient experienced swollen left sided supraclavicular lymph node, almost two weeks at the time of report and still swollen. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen left sided supraclavicular lymph node, almost two weeks at the time of report and still swollen was not resolved at the time of this report.

Other Meds: Metoprolol

Current Illness:

ID: 1725601
Sex: F
Age:
State: GA

Vax Date: 09/15/2021
Onset Date: 09/16/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Chills; Aches; Drowsiness; Dizziness; Nausea; Extreme pain starting from left arm up the left side of neck; Extreme pain starting from left arm up the left side of neck; Pain shooting down spine; Pain jabs in right side sinus cavities; Pain jabs in right side of frontal lobe; Itchy, red, hot spot where injected; Itchy, red, hot spot where injected; Itchy, red, hot spot where injected; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: JDAMH) via an unspecified route of administration in the left arm on 15Sep2021 at 17:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy and no other medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified birth control medicines (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD8448,) via an unspecified route of administration in the left arm on 25Aug2021 at 16:45 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. On 16Sep2021 at 03:30, the patient experienced chills, aches, drowsiness, dizziness, nausea, extreme pain starting from left arm up the left side of the neck, pain shooting down the spine, pain jabs in the right side of sinus cavities, pain jabs in the right side of the frontal lobe and the patient also developed itchy, red, hot spot where vaccine was injected. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, aches, drowsiness, dizziness, nausea, extreme pain starting from left arm up the left side of the neck, pain shooting down the spine, pain jabs in the right side of sinus cavities, pain jabs in the right side of the frontal lobe and itchy, red, hot spot where vaccine was injected was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1725602
Sex: F
Age:
State: IL

Vax Date: 09/10/2021
Onset Date: 09/10/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Cluster and single pustules, red in color, raised off the skin, itchy, scattered all over the body; Cluster and single pustules, red in color, raised off the skin, itchy, scattered all over the body; Patient was pregnant at the time of vaccination/ Gestation period: 16 weeks; COVID-19 vaccine start date: 10Sep2021 and Flu vaccine start date: 10Sep2021; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Sep2021 at 18:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. The patient's last menstrual date was 18May2021, gestational period was 16 weeks and expected delivery date was 22Feb2022. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient received other vaccine within four weeks prior to the COVID-19 vaccine which included first dose of influenza vaccine (FLU; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Sep2021 for an unknown indication. The patient did not receive any concomitant medications. On 11Sep2021 at 11:00, the patient experienced cluster and single pustules, red in color, raised off the skin, itchy and scattered all over the body. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events cluster and single pustules, red in color, raised off the skin, itchy, scattered all over the body was not resolved at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow-up.

Other Meds:

Current Illness:

ID: 1725603
Sex: F
Age:
State: TN

Vax Date: 07/22/2021
Onset Date: 09/12/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: First menstrual period after the vaccine has been full of the worst pain/have cramped intensely for several days; This is a spontaneous report from a contactable nurse. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 22Jul2021 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to nickel. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication was reported as not applicable (as per source document). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FW0181) via an unspecified route of administration in the left arm on 30Jun2021 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. On 12Sep2021, the patient experienced her first menstrual period after the vaccine had been full of the worst pain, the patient have had since she started her period 12 years ago. The patient had cramped intensely for several days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event first menstrual period after the vaccine has been full of the worst pain/have cramped intensely for several days was recovering at the time of this report.

Other Meds:

Current Illness:

ID: 1725604
Sex: M
Age:
State: FL

Vax Date: 09/17/2021
Onset Date: 09/17/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Fever; Headache; Vomiting; Patient received dose 3; Patient received dose 3; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 17Sep2021 at 08:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medication. The patient previously received first dose of COVID-19 VACCINE (MANUFACTURER UNKNOWN; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date and also second dose of COVID-19 VACCINE (MANUFACTURER UNKNOWN; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 18Sep2021 at 02:00 the patient experienced fever, headache, and vomiting. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with ondansetron (ZOFRAN), paracetamol (TYLENOL), and famotidine (PEPCID). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, headache, and vomiting was resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1725605
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Hormonal change; Swellness in the breast; Lost of hair; This is a spontaneous report from a non-contactable consumer, the patient. A non-pregnant female patient of unknown age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication was not reported. On an unknown date, the patient had hormonal change, swellness in the breast and lost of hair. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hormonal change, swellness in the breast and lost of hair was not resolved at the time of the report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1725606
Sex: F
Age:
State: GA

Vax Date: 09/14/2021
Onset Date: 09/14/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210913; Test Name: Nasal Swab; Test Result: Negative ; Test Date: 20210915; Test Name: Nasal Swab; Test Result: Negative ; Test Date: 20210917; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Facial numbness; Severe headaches; Shooting pain through head/skull; Blurred vision at times; Body aches; Fever; Chills; Sore arm; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FE3592) via an unspecified route of administration in the left arm on 14Sep2021 at 11:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included pacemaker for sick sinus syndrome, hypothyroidism and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included thyroid (ARMOUR THYROID), pantoprazole (MANUFACTURER UNKNOWN) and medroxyprogesterone (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. The patient previously received technetium tc 99m imidodiphosphate (TECHNETIUM 99M IDP) and propylthiouracil (PROPYLTHIURACIL); both for unknown indication on unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration in the left arm on 24Aug2021 at 12:15 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. On 13Sep2021, the patient underwent COVID-19 test via nasal swab and the result was negative. On 14Sep2021 at 13:00 the patient experienced facial numbness, severe headaches, shooting pain through head/skull, blurred vision at times, body aches, fever, chills, sore arm, and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 15Sep2021, the patient underwent COVID-19 test via nasal swab and the result was negative. On 17Sep2021, the patient underwent COVID-19 test via nasal swab and the result was negative. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events facial numbness, severe headaches, shooting pain through head/skull, blurred vision at times, body aches, fever, chills, sore arm, fatigue was not resolved at the time of this report.

Other Meds: ARMOUR THYROID; PANTOPRAZOLE; MEDROXYPROGESTERONE

Current Illness:

ID: 1725607
Sex: M
Age:
State: PA

Vax Date: 09/11/2021
Onset Date: 09/12/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Paining like a hit by something at the left side back shoulder; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Sep2021 at 17:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included covid-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 12Sep2021, the patient had paining like a hit by something at the left side back shoulder and the pain was there for three days. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event paining like a hit by something at the left side back shoulder was resolved on 15Sep2021. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1725608
Sex: F
Age:
State: NJ

Vax Date: 03/25/2021
Onset Date: 04/25/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Painful and delayed menstruation; Painful and delayed menstruation; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 25Mar2021 at 07:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Apr2021, the patient experienced painful and delayed menstruation. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events painful and delayed menstruation was resolved on an unknown date in 2021.

Other Meds:

Current Illness:

ID: 1725609
Sex: F
Age:
State: NJ

Vax Date: 02/15/2021
Onset Date: 02/15/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210826; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Had extreme heart palpitations.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3302) via an unspecified route of administration in the left arm on 15Feb2021 at 15:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included factor 5 Leiden and known allergy to strawberries. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL XR) and spironolactone (MANUFACTURER UNKNOWN); both from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Feb2021 at 19:45, the patient experienced extreme heart palpitations, at the time of this report the patient had them on and off throughout the day ever since. The patient never had heart palpitations prior to receiving the COVID-19 vaccine. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had been tested for COVID-19. On 26Aug2021, the patient underwent nasal swab test and the result was negative. The clinical outcome of the event extreme heart palpitations was not resolved at the time of this report.

Other Meds: ADDERALL; SPIRONOLACTONE

Current Illness:

ID: 1725610
Sex: F
Age:
State:

Vax Date: 09/15/2021
Onset Date: 09/15/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: "I" developed a dry cough /fatigue/congestion within 12 hrs of getting this vaccine; "I" developed a dry cough /fatigue/congestion within 12 hrs of getting this vaccine; "I" developed a dry cough /fatigue/congestion within 12 hrs of getting this vaccine; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 25-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 30135BA) via intramuscular route of administration in the right arm on 15Sep2021 at 11:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. It was unknown if the patient was pregnant at the time of vaccination. The patient had no medical history reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 15Sep2021, at 20:00, the patient developed dry cough, fatigue and congestion within 12 hours of getting this vaccine. It was also reported that these symptoms were still going on and it had been 4 days after receiving it. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures included treatment with benzonatate (MANUFACTURER UNKNOWN) 200MG capsule to help relieve the cough. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events developed a dry cough, fatigue and congestion within 12 hours of getting this vaccine was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1725611
Sex: F
Age:
State: NM

Vax Date: 09/07/2021
Onset Date: 09/14/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Missed menstrual cycle; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Sep2021 at 16:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included ulcerative colitis. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 14Sep2021 the patient experienced missed menstrual cycle. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event missed menstrual cycle was unknown at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1725612
Sex: F
Age:
State: MN

Vax Date:
Onset Date:
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210614; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Getting "my" periods every two weeks/The last four months "I" have gotten "my" period every two weeks; Gotten "my" period every two weeks. Heavier; Gotten "my" period every two weeks. Heavier and more cramps; Headaches; This is a spontaneous report from a contactable other healthcare professional, the patient. A 28-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included patient been on birth control and except when the patient was pregnant. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications were not reported. On an unknown date, the patient noticed getting periods every two weeks. The patient had been on birth control, except when the patient was pregnant for 12 years and was getting period on the dot with pills. Since last four months, the patient has gotten period every two weeks, heavier and more cramps and headaches as well. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 14Jun2021, the patient underwent COVID-19 test via nasal swab and the result was negative. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events getting periods every two weeks, last four months have gotten period every two weeks, heavier, more cramps and headaches was unknown at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1725613
Sex: F
Age:
State: NY

Vax Date: 07/07/2021
Onset Date: 07/07/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Unevaluable event

Symptoms: Racing heart; Hot feeling through body; Burning sensation in lungs; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Jul2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to sulfa and penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 07Jul2021, 10 minutes after dose 1, the patient experienced racing heart, hot feeling through body and burning sensation in lungs. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department visit or urgent care. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in 2021, the patient underwent COVID-19 test via nasal swab and the result was negative. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events racing heart, hot feeling through body and burning sensation in lungs was resolved on an unknown date in 2021. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1725614
Sex: F
Age:
State: WV

Vax Date: 09/17/2021
Onset Date: 09/17/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies: Allergy to nuts (known allergies: Hazelnut)

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: This is a spontaneous report from a contactable other healthcare professional (patient). A 41-year-old non-pregnant female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# FC3184), at the age of 41, via an unspecified route of administration, left arm, on Sep 17, 2021, at 08:30, single dose, for COVID-19 immunisation. Medical history included allergy to hazelnut. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medication. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0172), at the age of 41, via an unspecified route of administration, left arm, on Aug 27, 2021, at 09:15, single dose, for COVID-19 immunisation. On Sep 17, 2021 at 09:15, patient felt flushed, had tingling in left arm and hand, also felt very dizzy and very tired. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The outcome of feeling flushed, tingling in left arm and hand, feeling very dizzy, and very tired were not resolved at the time of this report.

Other Meds:

Current Illness:

ID: 1725615
Sex: F
Age:
State: NC

Vax Date: 09/16/2021
Onset Date: 09/17/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210917; Test Name: Body temperature; Result Unstructured Data: Test Result:102.9 fever; Comments: 102.9 fever that started 15 hours after vaccine

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Right knee pain; Arm pain; Felt extremely ill and weak; Felt extremely ill and weak; 102.9 fever; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 0911995-07981) via an unspecified route of administration in the right arm on 16Sep2021 at 18:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient did not have medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 0904499-07981) via an unspecified route of administration and unspecified anatomical location on an unspecified date (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On 17Sep2021 at 09:00, the patient reports 102.9 fever that started 15 hours after vaccine, and lasted 12 hours. On 17Sep2021 at 10:15 patient experienced right knee pain, arm pain and also felt extremely ill and weak. It was unreported if therapeutic measures were taken as a result of events 102.9 fever, right knee pain, arm pain, felt extremely ill and weak. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event 102.9 fever was resolved and of the events right knee pain, arm pain, felt extremely ill and weak was resolving at the time of report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1725616
Sex: F
Age:
State: OH

Vax Date: 09/17/2021
Onset Date: 09/18/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210919; Test Name: Body temperature; Result Unstructured Data: Test Result:102; Comments: Fever remaining at 102 at hour 32; Test Date: 20210918; Test Name: Body temperature; Result Unstructured Data: Test Result:102; Comments: Fever 102 at 12 hours (reported at 03:30)

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Fever 102; Fatigue; Headache; Dizziness; Weak; This is a spontaneous report from a non-contactable consumer, the patient. A 13-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Sep2021 at 16:30 (at the age of 13-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies (reported as none that the patient knew of). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Aug2021 at 16:30 (at the age of 13-years-old) as a single dose for COVID-19 immunisation. On 18Sep2021 at 03:30 (reported as 12 hours after second shot), the patient experienced fever 102 (unspecified units), fatigue, headache, dizziness and was weak. On 19Sep2021 at 00:30, at hour 32, the fever remained at 102 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with paracetamol (TYLENOL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever 102 (unspecified units), headache, fatigue, dizziness, and weak was not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1725617
Sex: M
Age:
State: OR

Vax Date: 08/24/2021
Onset Date: 08/26/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Gout - painful gout in right toe; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0191) via an unspecified route of administration in the left arm on 24Aug2021 at 13:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 03Aug2021 at 13:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. On 26Aug2021 at 07:00, the patient experienced gout - painful gout in right toe. The event resulted in a visit to the doctors or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event gout-painful gout in the right toe and included treatment with unspecified medications. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event gout - painful gout in right toe was not resolved at the time of this report.

Other Meds:

Current Illness:

ID: 1725618
Sex: M
Age:
State: MD

Vax Date: 09/11/2021
Onset Date: 09/13/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Extremely itchy eyes; Slight swelling under eyes; Redness of eyes; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8839) via an unspecified route of administration in the left arm on 11Sep2021 at 12:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications were not reported. On 13Sep2021 the patient experienced extremely itchy eyes, slight swelling under eyes and redness of eyes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extremely itchy eyes, slight swelling under eyes and redness of eyes was not resolving at the time of this report.

Other Meds:

Current Illness:

ID: 1725619
Sex: F
Age:
State: AK

Vax Date: 09/19/2021
Onset Date: 09/19/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Pain at injection site; Dehydration; Fatigue; Unable to sleep; Shaky/unbalanced; Shaky/unbalanced; This was the booster shot.; This was the booster shot.; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received third dose (booster dose) of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 301308A) via an unspecified route of administration in the right arm on 19Sep2021 at 12:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on unknown dates as a single dose for COVID-19 immunisation and reportedly no reactions to first 2 shots. On 19Sep2021 at 13:30 the patient experienced pain at injection site, dehydration, fatigue but unable to sleep, shaky/unbalanced. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain at injection site, dehydration, fatigue but unable to sleep, shaky/unbalanced was not recovered at the time of this report.

Other Meds:

Current Illness:

ID: 1725620
Sex: F
Age:
State: OH

Vax Date: 09/17/2021
Onset Date: 09/18/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Lymphedema right collar; This is a spontaneous report from a contactable nurse, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 30130BA) via an unspecified route of administration in the right arm on 17Sep2021 at 16:30 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176), via an unspecified route of administration in the left arm on 16Aug2021 at 16:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 18Sep2021 at 04:00, the patient experienced lymphedema right collar. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported event. The clinical outcome of the event lymphedema right collar was not resolved at the time of this report.

Other Meds:

Current Illness:

ID: 1725621
Sex: F
Age:
State: MD

Vax Date: 09/01/2021
Onset Date: 09/01/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Continue to have pain and numbness to left arm.; Continue to have pain and numbness to left arm.; Chest pain on left side; This is a spontaneous report from a contactable other healthcare professional, the patient. A 42-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the left arm on 01Sep2021 at 13:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3180) via an unspecified route of administration in the left arm on 09Aug2021 at 15:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 01Sep2021 at 15:00, the patient continued to had pain and numbness to left arm. The patient also had chest pain on left side. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events continue to have pain and numbness to left arm and chest pain on left side was not recovered at the time of this report.

Other Meds:

Current Illness:

ID: 1725622
Sex: F
Age:
State: MO

Vax Date: 09/15/2021
Onset Date: 09/16/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210916; Test Name: Body temperature; Result Unstructured Data: Test Result:102; Comments: Fever

Allergies:

Symptom List: Injection site pain

Symptoms: Arm sore; Fever of 102 for 2 days; Back aches; Diarrhea/upset stomach; Diarrhea/upset stomach; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the left arm on 15Sep2021 at 16:45 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included drospirenone/ ethinylestradiol betadex clathrate (YAZ) started from an unknown date taken daily for birth control. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD8448) via an unspecified route of administration in the left arm on 27Aug2021 at 15:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. On 16Sep2021 at 13:15, the patient experienced arm sore, fever of 102 for 2 days, back aches, diarrhea/upset stomach, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 16Sep2021, the patient underwent lab test body temperature and the result was 102 (units unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm sore, back aches, diarrhea/upset stomach, headache and fatigue were resolved on an unknown date in Sep2021; while the event fever of 102 for 2 days was resolved on 18Sep2021, after the duration of 2 days.

Other Meds: YAZ

Current Illness:

ID: 1725623
Sex: M
Age:
State: VA

Vax Date: 09/19/2021
Onset Date: 09/19/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Sciatic nerve pain; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the arm right on 19Sep2021 at 11:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and paracetamol (ACETAMINOPHEN); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the arm right on 22Aug2021 at 10:45 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. On 19Sep2021 at 23:00, the patient experienced sciatic nerve pain. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sciatic nerve pain was not resolved at the time of this report.

Other Meds: IBUPROFEN; ACETAMINOPHEN

Current Illness:

ID: 1725624
Sex: F
Age:
State: TN

Vax Date: 09/17/2021
Onset Date: 09/18/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210821; Test Name: Nasal swab; Test Result: Negative

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: "I" started to feel really tired; Had a delusion of seeing balloons on the road; "I" started to feel nauseated; "I" slept for about 16-19 hours; This is a spontaneous report from a contactable nurse, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2088) via intramuscular route of administration in the left arm on 17Sep2021 at 19:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 21Aug2021, the patient underwent nasal swab test for COVID-19 and the result was negative. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via intramuscular route of administration in the right arm on 27Aug2021 at 19:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. In the morning on 18Sep2021 (saturday), the patient felt fine. After having lunch on 18Sep2021, the patient started to feel nauseated and about forty minutes after, she started to feel really tired and had a delusion of seeing balloons on the road. The patient's husband was driving in the car and she asked if he saw what she saw and he told no. Once they were home, the patient slept for about 16 to19 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events "I" started to feel nauseated, "I" started to feel really tired and had a delusion of seeing balloons on the road was resolved on an unspecified date in Sep2021 while the clinical outcome of the event "I" slept for about 16-19 hours was resolved on 19Sep2021.

Other Meds:

Current Illness:

ID: 1725625
Sex: F
Age:
State: VA

Vax Date: 08/30/2021
Onset Date: 08/30/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Pain in left neck from shoulder to ear for 48 hours; Diarrhea; Swollen & Numb lips; Swollen & Numb lips; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 3182) via an unspecified route of administration in the left arm on 30Aug2021 at 18:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient's medical history reported as not applicable. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were reported as N/A. On 30Aug2021 at 20:00, the patient experienced pain in left neck from shoulder to ear for 48 hours, diarrhea for 24 hours and swollen and numb lips for 48 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event diarrhea was resolved on 31Aug2021, after the duration of 24 hours; while that of the events pain in left neck from shoulder to ear and swollen and numb lips were resolved on 01Sep2021, after the duration of 48 hours.

Other Meds:

Current Illness:

ID: 1725626
Sex: F
Age:
State: OK

Vax Date: 09/07/2021
Onset Date: 09/07/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Left arm itches right where the injections site is and aches like a tooth ache; Left arm itches right where the injections site is and aches like a tooth ache; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration in the left arm on 07Sep2021 at 10:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID), colecalciferol (VITAMIN D3), montelukast sodium (SINGULAIR), unspecified probiotics and cholesterol pill; all for unknown indication from unknown date and unknown if ongoing. On 07Sep2021 at 11:00, the patient's left arm was itching right where the injections site was and ached like a tooth ache. The events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left arm itches right where the injections site is and aches like a tooth ache was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: SYNTHROID; VITAMIN D3; SINGULAIR

Current Illness:

ID: 1725627
Sex: F
Age:
State: FL

Vax Date: 09/17/2021
Onset Date: 09/18/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data: Test Date: 20210918; Test Name: Body temperature; Result Unstructured Data: Test Result:101; Comments: Fever of 101

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Right ankle swollen for 2 days; Body aches; Fever of 101; Extreme headache; Sore throat; Ear ache; Hives; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 301308A) via an unspecified route of administration in the left arm on 17Sep2021 at 12:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included acyclovir (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: PC3183) via an unspecified route of administration in the left arm on 27Aug2021 at 11:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 18Sep2021 at 06:00, the patient had right ankle swollen for 2 days, body aches, fever of 101, extreme headache, sore throat, ear ache, hives and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event right ankle swollen for 2 days was resolved on an unknown date in Sep2021 while that of the events body aches, fever of 101, extreme headache, sore throat, ear ache, hives and dizziness was not resolved at the time of the report.

Other Meds: ACYCLOVIR [ACICLOVIR]

Current Illness:

ID: 1725628
Sex: F
Age:
State: NJ

Vax Date: 09/15/2021
Onset Date: 09/15/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Nausea; Vomiting; Headache; Fever; Body aches; Chills; Joint pain, hip pain; Spinal pain; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 15Sep2021 at 07:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ocrelizumab (OCREVUS) and fluvoxamine maleate (LUVOX); both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on an unknown date in Aug2021 at 07:15 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient previously also received azithromycin (ZITHROMAX) and gadolinium (MANUFACTURER UNKNOWN) and experienced drug allergy. On 15Sep2021 at 15:00, the patient experienced nausea, vomiting, headache, fever, body aches, chills, joint pain, hip pain, spinal pain and fatigue. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, vomiting, headache, fever, body aches, chills, joint pain, hip pain, spinal pain and fatigue was recovered with sequelae (reported as recovered with lasting effects) on an unknown date in Sep2021.

Other Meds: OCREVUS; LUVOX [FLUVOXAMINE MALEATE]

Current Illness:

ID: 1725629
Sex: F
Age:
State:

Vax Date: 06/23/2021
Onset Date: 06/23/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210724; Test Name: PCR test; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Upper extremity swelling; Neck swelling; Headache; General fatigue; Malaise; Menstrual irregularity including long menstruation (15 days); Menstrual irregularity including long menstruation (15 days); Hot flashes; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration on 23Jun2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included scoliosis, premenstrual syndrome (PMS) and allergy to sulfa drugs. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included fluoxetine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. On 23Jun2021 at 22:00, the patient experienced upper extremity swelling, neck swelling, headache, general fatigue and malaise. The patient also reported menstrual irregularity including long menstruation (15 days) and hot flashes. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 24Jul2021, the patient underwent polymerase chain reaction (PCR) test via nasal swab and the result was negative. The clinical outcome of the events upper extremity swelling, neck swelling, headache, general fatigue, malaise, menstrual irregularity including long menstruation (15 days) and hot flashes was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: FLUOXETINE

Current Illness:

ID: 1725630
Sex: F
Age:
State: PA

Vax Date: 05/11/2021
Onset Date: 05/01/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Extremely heavy and long periods; Along with worst cramps "I" have ever experienced.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 11May2021 at 08:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks of vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 20Apr2021 at 08:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On an unknown date in May2021, the patient had extremely heavy and long periods along with worst cramps that patient had ever experienced. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extremely heavy and long periods along with worst cramps was unknown at the time of this report.

Other Meds:

Current Illness:

ID: 1725631
Sex: F
Age:
State: TX

Vax Date: 02/01/2021
Onset Date:
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Shingles; This is a spontaneous report from a contactable consumer or other non-HCP (patient's daughter). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on Feb2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient's daughter stated her mom received the Pfizer vaccine in Feb2021 at a different location and she never reported back about symptoms, but she got shingles after her second dose on an unspecified date 2021. The outcome of the event was unknown. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1725632
Sex: M
Age:
State: CA

Vax Date: 08/17/2021
Onset Date: 08/17/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Swollen Lymph Nodes; Pain; This is a spontaneous report from a contactable consumer, the patient. A 13-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3180) via an unspecified route of administration in the left arm on 17Aug2021 (at the age of 13-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications were not reported. The patient previously received amoxicillin (AMOXICILLINE) on an unknown date for an unknown indication and experienced drug allergy. On 17Aug2021, the patient experienced swollen lymph nodes and pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen lymph nodes and pain were resolved on an unknown date in 2021.

Other Meds:

Current Illness:

ID: 1725633
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data: Test Name: Blood pressure; Result Unstructured Data: Test Result:okay; Test Name: Pulse Rate; Result Unstructured Data: Test Result:118; Comments: pulse was 118.

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: pulse was 118; slight, slight chest pain/she had chest pain so bad it almost took her to the floor; This is a spontaneous report from a contactable consumer (patient) reported for herself. A female patient of an unspecified age received an unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date (also reported as on the 15th) (age at vaccination was unknown) as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the Pfizer COVID vaccine on the 15th. On an unspecified date, the patient experienced slight, slight chest pain that day. The following day, she had chest pain so bad it almost took her to the floor and caused her to be hunched over holding her chest. It lasted for about 4 min. She went home after that and measured her blood pressure and pulse and noted her blood pressure was okay, but her pulse was 118 on an unspecified date. The outcome of the event slight, slight chest pain/she had chest pain so bad it almost took her to the floor was resolved on an unspecified date in 2021. The outcome of the event pulse was 118 was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1725634
Sex: F
Age:
State: TX

Vax Date: 09/17/2021
Onset Date: 09/17/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210918; Test Name: Body temperature; Result Unstructured Data: Test Result:98.5; Test Date: 20210917; Test Name: Body temperature; Result Unstructured Data: Test Result:99.4 and went up to 101.3; Comments: at 20:30

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Fatigue; Day of shot exactly 12 hours after the shot at 20:30 the bodyaches started; chills; Fever started at 99.4 and went up to 101.3; This is a spontaneous report from a contactable healthcare professional, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the right arm on 17Sep2021 at 08:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included stage 3 rectal cancer since an unknown date in 2016 (now in remission for 5 years), benign desmoid tumor since an unknown date in Mar2021, radiation finished in Jul2021, anxiety and depression. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the right arm on 27Aug2021 at 10:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient previously received lorazepam (ATIVA) and citalopram hydrobromide (CELEXA); both for anxiety and depression from an unknown date and unknown if ongoing. On 17Sep2021 at 20:30, after the second dose of vaccine on the day of the shot, exactly 12 hours after the shot, the patient experienced body aches, followed by chills and fever. The fever started at 99.4 (unspecified units) and went up to 101.3 (units not specified), was reduced soon by taking naproxen sodium to reduce the fever. Ice packs and cold washcloths helped with the fever too. She was then fever free by 18Sep2021 morning with 98.5 temperature (units not specified). On 18Sep2021, she still had body aches and fatigue, so she rested. On 19Sep2021, she felt better and like herself again. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events the body aches started, chills and fatigue. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fever started at 99.4 and went up to 101.3 was recovered on 18Sep2021. The clinical outcome of the events day of shot exactly 12 hours after the shot at 20:30 the body aches started, chills, and fatigue were recovered on 19Sep2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1725635
Sex: F
Age:
State:

Vax Date: 09/03/2021
Onset Date: 09/03/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Major dizziness; Breathing like a fish out of water; Wheezing; Squeaking; Coughing; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 03Sep2021 at 08:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid, allergy to lots of things, environmental, food, and chemical allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ARMOUR THYROID and LORATSDINE for an unknown indication from an unknown date and unknown if ongoing. On 03Sep2021, the patient experienced major dizziness within 2 minutes of injection which lasted continually for 5 hours, intermittently for 7 days with breathing like a fish out of water, wheezing, squeaking and coughing started an hour after injection and was continued badly for an hour, reasonably for 2 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included ALBUTEROL inhaler 2 times, hot packs, hot tea, and bed. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events major dizziness, breathing like a fish out of water, wheezing, squeaking and coughing was resolved with lasting effects on an unknown date in Sep2021 at the time of report. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ARMOUR THYROID; LORATADINE

Current Illness:

ID: 1725636
Sex: F
Age:
State: TN

Vax Date: 08/28/2021
Onset Date: 08/28/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: No menstrual cycle after vaccine; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Aug2021 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Aug2021, the patient experienced no menstrual cycle after vaccine. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event no menstrual cycle after vaccine was not resolved at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1725637
Sex: F
Age:
State: OH

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Lost all ability to sit upright; Lost ability to stand; Lost ability to walk; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 17Mar2021 at 13:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic depression and known allergies to antibiotics. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202), via an unspecified route of administration in the left arm on 24Feb2021 at 13:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. On 17Mar2021 at 18:00, the patient lost all ability to sit upright, lost ability to stand and lost ability to walk, which lasted about 14 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lost all ability to sit upright, lost ability to stand and lost ability to walk was recovered with sequelae on 18Mar2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1725638
Sex: F
Age:
State: CA

Vax Date: 01/01/2021
Onset Date: 03/01/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 2021; Test Name: Blood work; Result Unstructured Data: Test Result:Unknown results; Test Date: 2021; Test Name: Ultrasound; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Developed period like cramps for a whole month; Being light-headed frequently; In addition her cycle became irregular resulting in 5 months of missed period, this was not normal due to having regular cycles, to this day Sep2021 she still had missing and or skipping months of periods; This is a spontaneous report from a contactable other healthcare professional, the patient. A 25-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the right arm on an unknown date in Jan2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1284) via an unspecified route of administration in the left arm on 31Dec2020 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Mar2021, after second dose of vaccination, the patient developed period like cramps for a whole month. Then she was being light headed frequently. In addition, her cycle became irregular resulting in 5 months of missed period. This was not normal due to having regular cycles. It was reported that, to this day Sep2021 the patient was still missing and or skipping months of periods. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included lab tests with ultrasound and blood work on an unknown date in 2021 and results were unknown. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events developed period like cramps for a whole month and being light headed frequently was unknown; whereas for event and cycle became irregular resulting in 5 months of missed period, this was not normal due to having regular cycles, to this day Sep2021 she still had missing and or skipping months of periods was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1725639
Sex: F
Age:
State: TN

Vax Date: 08/19/2021
Onset Date: 08/19/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Shingle-like symptoms; Dizziness; Stomach cramping; Neck stiffness; Chest pains; This is a spontaneous report from a contactable pharmacist, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0202) via an unspecified route of administration in left arm on 19Aug2021 at 14:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as not available. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received azithromycin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and experienced allergy to antibiotic. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 19Aug2021 at 16:00, the patient experienced shingle-like symptoms, dizziness, stomach cramping, neck stiffness and chest pains. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shingle-like symptoms, dizziness, stomach cramping, neck stiffness and chest pains was not resolved at the time of report.

Other Meds:

Current Illness:

ID: 1725640
Sex: F
Age:
State: AZ

Vax Date: 09/08/2021
Onset Date: 09/09/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Bad headaches; Extreme fatigue; Hot flashes; Vertigo; Weakness; Left hand to left elbow tingling; Left hand to left elbow tingling with pain; Left hand to left elbow tingling with pain; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the left arm on 08Sep2021 at 14:30 (at the age of 72-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included atenolol (MANUFACTURER UNKNOWN), amitriptyline (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and alendronate sodium (ALENDRONAT) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Sep2021 at 09:00 the patient experienced bad headaches, extreme fatigue, hot flashes, vertigo, weakness, left hand to left elbow tingling, left elbow pain and left-hand pain. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events bad headaches, extreme fatigue, hot flashes, vertigo, weakness, left hand to left elbow tingling, left elbow pain and left hand pain were not recovered at the time of this report.

Other Meds: ATENOLOL; AMITRIPTYLINE; ATORVASTATIN; ALENDRONAT

Current Illness:

ID: 1725641
Sex: F
Age:
State: CA

Vax Date: 08/24/2021
Onset Date: 08/25/2021
Rec V Date: 09/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210910; Test Name: Nasal Swab; Test Result: Negative ; Test Date: 20210827; Test Name: Nasal Swab; Test Result: Positive

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Headache; Low grade fever; Nausea; Depression; Weak; No appetite; Cough; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 24Aug2021 at 09:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously took ranitidine hydrochloride (ZANTAC) and morphine sulfate (MORPHINE) and experienced drug allergy. On 25Aug2021 at 07:00, the patient experienced headache, low grade fever, nausea, depression, weak, no appetite and cough. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. On 27Aug2021, the patient underwent nasal swab test for COVID-19 and the result was positive. On 10Sep2021, the patient underwent nasal swab test for COVID-19 and the result was negative. The clinical outcome of the events headache, low grade fever, nausea, depression, weak, no appetite and cough was resolved with sequelae (reported as patient recovered with lasting effects) on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am